http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2291366-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e61263b84630539d1fc5281e3bd9ac4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b2710fc436b8878c41e7b12250bba5a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-08
filingDate 2009-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a51930aee4913a30729d6d49723e11b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a90356f5ac1829615f499bdb7aa71567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e04a0a1b73b2f6e9f02acfec8ba7d5f0
publicationDate 2011-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2291366-A2
titleOfInvention Preparation of imatinib mesylate
abstract Processes for preparing a non-hygroscopic and stable crystalline alpha-form imatinib mesylate.
priorityDate 2008-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008090833-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226478780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129473095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226680998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414871561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129443877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2841573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454269980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421239439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66661131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127737393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028

Total number of triples: 58.